Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$52,477,953
-$11,697,286 QoQ
Shares Held
2,179,317
-4.6% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#168
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Grantham, Mayo, Van Otterloo & Co. LLC holds $3,887,775,493 across 10 Drug Manufacturers - General names. PFE ranks #5 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
7,110,133 | $1,805,760,478 | |
| 2 | LLY |
ELI LILLY & Co
|
743,966 | $892,335,213 | |
| 3 | MRK |
Merck & Co., Inc.
|
6,785,008 | $871,873,528 | |
| 4 | GSK |
GSK plc
|
3,599,521 | $188,686,890 | |
| 5 | PFE |
Pfizer Inc
This page
|
2,179,317 | $52,477,953 | |
| 6 | NVS |
Novartis AG
|
245,957 | $38,546,381 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
411,483 | $23,709,650 | |
| 8 | SNY |
Sanofi
|
285,165 | $12,165,138 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $52,477,953 | 2,179,317 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $64,175,239 | 2,285,443 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $59,236,328 | 2,378,969 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $61,693,755 | 2,421,262 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $61,918,801 | 2,554,406 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $72,982,392 | 2,880,126 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $71,013,859 | 2,676,738 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $64,011,025 | 2,211,853 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $73,307,991 | 2,620,014 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $67,849,998 | 2,445,045 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $74,718,946 | 2,595,309 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $75,426,490 | 2,273,937 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $70,951,884 | 1,934,348 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $59,373,384 | 1,455,230 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $57,216,121 | 1,116,630 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $35,439,473 | 809,860 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $42,967,538 | 819,522 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $9,490,579 | 183,322 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $21,118,937 | 357,645 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $35,060,891 | 815,180 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $29,790,186 | 760,730 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $13,737,872 | 379,185 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $6,080,459 | 165,185 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $6,814,632 | 185,685 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $5,990,155 | 183,185 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $9,090,978 | 278,523 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||